[IF=11.1]LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease-EMBO Mol Med(2023)15: e16581
发布日期：2024/5/15 13:34:23
作者：Mi Bai, Mengqiu Wu , Mingzhu Jiang, Jia He , Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang Yue Zhang, Songming Huang, Li Yang Zhanjun Jia Aihua Zhang
期刊：EMBO Molecular Medicine
DOI： 10.15252/emmm.202216581
影响因子 ：11.1
引用产品：[FS1166] JC-1线粒体膜电位检测试剂盒
期刊：EMBO Molecular Medicine
DOI： 10.15252/emmm.202216581
影响因子 ：11.1
引用产品：[FS1166] JC-1线粒体膜电位检测试剂盒
上一篇：[IF=12.4]Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2-Molecular Therapy-Published:April 22, 2023DOI:https://doi.org/10.1016/j.omtn.2023.04.021
下一篇：[IF=27.5]Hydrogen Sulfide Positively Regulates Abscisic Acid Signaling through Persulfidation of SnRK2.6 in Guard Cells-Published:July 06, 2021.DOI:https://doi.org/10.1016/j.molp.2021.07.002
下一篇：[IF=27.5]Hydrogen Sulfide Positively Regulates Abscisic Acid Signaling through Persulfidation of SnRK2.6 in Guard Cells-Published:July 06, 2021.DOI:https://doi.org/10.1016/j.molp.2021.07.002
.jpg)
